Eglet Wall Christiansen has hit the jackpot twice since 2010 with half-­billion-dollar verdicts against companies culpable for hepatitis outbreaks.

In April 2013, the firm scored a $524 million verdict, including $500 million in punitive damages, in a consolidated trial of two Nevada state court cases over hepatitis C infections.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]